SPONSOR
Changhai Hospital
Total Trials
9
Recruiting
9
Phases
Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: Inflammatory Bowel DiseasesColitisIBD (Inflammatory Bowel Disease)Probiotic InterventionChronic Hepatitis bNon-Small Cell Lung CancerLocalized Prostate CancerColonoscopyColonoscopy: Bowel PreparationBladder Cancer
NCT06512441
Recruiting
Vitamin B6 Aids in Treating Inflammatory Bowel Disease
Inflammatory Bowel Diseases
NCT07047339 Phase 2, Phase 3
Recruiting
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
Colitis
NCT06885710 Phase 1
Recruiting
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
Chronic Hepatitis b
NCT06394674 Phase 2
Recruiting
High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib
Non-Small Cell Lung Cancer
NCT06325774
Recruiting
Radical Hypofractionated Radiotherapy for Localized Prostate Cancer
Localized Prostate Cancer
NCT07335705
Recruiting
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients
IBD (Inflammatory Bowel Disease)
NCT07204132
Recruiting
Investigation Into the Integration of Intracavitary Cryoablation and Immunotherapy in Bladder-Preserving Therapy
Bladder Cancer
NCT06427460 Phase 2
Recruiting
Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
Pancreatic Cancer
NCT06816823 Phase 1
Recruiting
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
Pancreatic Cancer